The global Pharma-Grade Hyaluronic Acid market size was valued at US$ 188 million in 2024 and is forecast to a readjusted size of USD 370 million by 2031 with a CAGR of 10.1% during review period.
Hyaluronic acid is a naturally occurring substance that helps retain moisture in the skin and eyes and lubricates the joints. Pharma-Grade Hyaluronic Acid is generally used in pharmaceutical formulations, such as Injection Product and Eye Drops for osteoarthritis of the knee joint.
Hyaluronic acid also called hyaluronan, is an anionic, nonsulfated glycosaminoglycan distributed widely throughout connective, epithelial, and neural tissues. It is unique among glycosaminoglycans in that it is nonsulfated, forms in the plasma membrane instead of the Golgi apparatus, and can be very large: human synovial HA averages about 7 million Da per molecule, or about 20000 disaccharide monomers, while other sources mention 3鈥�4 million Da. As one of the chief components of the extracellular matrix, hyaluronan contributes significantly to cell proliferation and migration, and may also be involved in the progression of some malignant tumors. In this report, we only study the Pharma-Grade Hyaluronic Acid.
The rising preference rates and applications of hyaluronic acid products in dry eye and osteoarthritis management fuels the growth rate of the market significantly. the growing prevalence of osteoarthritis has fueled demand for hyaluronic acid-based treatments, as it is used in viscosupplementation injections to relieve joint pain. Rising consumer awareness of health, along with advancements in biotechnology, has further expanded the market's growth.
However, adverse effects associated with treatment or therapy such as redness and itching, as well as high production costs and regulatory hurdles. The process of extracting and purifying hyaluronic acid, particularly from natural sources, can be expensive, leading to higher product prices. Additionally, the stringent regulatory requirements for pharmaceutical-grade products create barriers for manufacturers, as they must meet rigorous standards for safety and efficacy. These factors can limit the entry of new players into the market and slow down overall growth.
Global key players of pharma-grade hyaluronic acid include Bloomage Biotech, HTL Biotechnology, Kewpie, Contipro, Fidia Farmaceutici, etc. The top five players hold a share about 78%. Europe is the largest market, has a share about 51%, followed by North America and Asia-Pacific , with share 26% and 21%, separately.
This report is a detailed and comprehensive analysis for global Pharma-Grade Hyaluronic Acid market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Pharma-Grade Hyaluronic Acid market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2020-2031
Global Pharma-Grade Hyaluronic Acid market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2020-2031
Global Pharma-Grade Hyaluronic Acid market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2020-2031
Global Pharma-Grade Hyaluronic Acid market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (US$/Kg), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pharma-Grade Hyaluronic Acid
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pharma-Grade Hyaluronic Acid market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bloomage Biotech, AWA Biopharm, Kewpie, Contipro, Seikagaku, HTL Biotechnology, 贵颈诲颈补听贵补谤尘补肠别耻迟颈肠颈, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
Pharma-Grade Hyaluronic Acid market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Microbial Fermentation
Animal Tissue
麻豆原创 segment by Application
Injection Product
Eye Drops
Major players covered
Bloomage Biotech
AWA Biopharm
Kewpie
Contipro
Seikagaku
HTL Biotechnology
贵颈诲颈补听贵补谤尘补肠别耻迟颈肠颈
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pharma-Grade Hyaluronic Acid product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pharma-Grade Hyaluronic Acid, with price, sales quantity, revenue, and global market share of Pharma-Grade Hyaluronic Acid from 2020 to 2025.
Chapter 3, the Pharma-Grade Hyaluronic Acid competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pharma-Grade Hyaluronic Acid breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Pharma-Grade Hyaluronic Acid market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pharma-Grade Hyaluronic Acid.
Chapter 14 and 15, to describe Pharma-Grade Hyaluronic Acid sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Pharma-Grade Hyaluronic Acid Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Microbial Fermentation
1.3.3 Animal Tissue
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Pharma-Grade Hyaluronic Acid Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Injection Product
1.4.3 Eye Drops
1.5 Global Pharma-Grade Hyaluronic Acid 麻豆原创 Size & Forecast
1.5.1 Global Pharma-Grade Hyaluronic Acid Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Pharma-Grade Hyaluronic Acid Sales Quantity (2020-2031)
1.5.3 Global Pharma-Grade Hyaluronic Acid Average Price (2020-2031)
2 Manufacturers Profiles
2.1 Bloomage Biotech
2.1.1 Bloomage Biotech Details
2.1.2 Bloomage Biotech Major Business
2.1.3 Bloomage Biotech Pharma-Grade Hyaluronic Acid Product and Services
2.1.4 Bloomage Biotech Pharma-Grade Hyaluronic Acid Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Bloomage Biotech Recent Developments/Updates
2.2 AWA Biopharm
2.2.1 AWA Biopharm Details
2.2.2 AWA Biopharm Major Business
2.2.3 AWA Biopharm Pharma-Grade Hyaluronic Acid Product and Services
2.2.4 AWA Biopharm Pharma-Grade Hyaluronic Acid Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 AWA Biopharm Recent Developments/Updates
2.3 Kewpie
2.3.1 Kewpie Details
2.3.2 Kewpie Major Business
2.3.3 Kewpie Pharma-Grade Hyaluronic Acid Product and Services
2.3.4 Kewpie Pharma-Grade Hyaluronic Acid Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Kewpie Recent Developments/Updates
2.4 Contipro
2.4.1 Contipro Details
2.4.2 Contipro Major Business
2.4.3 Contipro Pharma-Grade Hyaluronic Acid Product and Services
2.4.4 Contipro Pharma-Grade Hyaluronic Acid Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Contipro Recent Developments/Updates
2.5 Seikagaku
2.5.1 Seikagaku Details
2.5.2 Seikagaku Major Business
2.5.3 Seikagaku Pharma-Grade Hyaluronic Acid Product and Services
2.5.4 Seikagaku Pharma-Grade Hyaluronic Acid Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Seikagaku Recent Developments/Updates
2.6 HTL Biotechnology
2.6.1 HTL Biotechnology Details
2.6.2 HTL Biotechnology Major Business
2.6.3 HTL Biotechnology Pharma-Grade Hyaluronic Acid Product and Services
2.6.4 HTL Biotechnology Pharma-Grade Hyaluronic Acid Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 HTL Biotechnology Recent Developments/Updates
2.7 贵颈诲颈补听贵补谤尘补肠别耻迟颈肠颈
2.7.1 贵颈诲颈补听贵补谤尘补肠别耻迟颈肠颈 Details
2.7.2 贵颈诲颈补听贵补谤尘补肠别耻迟颈肠颈 Major Business
2.7.3 贵颈诲颈补听贵补谤尘补肠别耻迟颈肠颈 Pharma-Grade Hyaluronic Acid Product and Services
2.7.4 贵颈诲颈补听贵补谤尘补肠别耻迟颈肠颈 Pharma-Grade Hyaluronic Acid Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 贵颈诲颈补听贵补谤尘补肠别耻迟颈肠颈 Recent Developments/Updates
3 Competitive Environment: Pharma-Grade Hyaluronic Acid by Manufacturer
3.1 Global Pharma-Grade Hyaluronic Acid Sales Quantity by Manufacturer (2020-2025)
3.2 Global Pharma-Grade Hyaluronic Acid Revenue by Manufacturer (2020-2025)
3.3 Global Pharma-Grade Hyaluronic Acid Average Price by Manufacturer (2020-2025)
3.4 麻豆原创 Share Analysis (2024)
3.4.1 Producer Shipments of Pharma-Grade Hyaluronic Acid by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2024
3.4.2 Top 3 Pharma-Grade Hyaluronic Acid Manufacturer 麻豆原创 Share in 2024
3.4.3 Top 6 Pharma-Grade Hyaluronic Acid Manufacturer 麻豆原创 Share in 2024
3.5 Pharma-Grade Hyaluronic Acid 麻豆原创: Overall Company Footprint Analysis
3.5.1 Pharma-Grade Hyaluronic Acid 麻豆原创: Region Footprint
3.5.2 Pharma-Grade Hyaluronic Acid 麻豆原创: Company Product Type Footprint
3.5.3 Pharma-Grade Hyaluronic Acid 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Pharma-Grade Hyaluronic Acid 麻豆原创 Size by Region
4.1.1 Global Pharma-Grade Hyaluronic Acid Sales Quantity by Region (2020-2031)
4.1.2 Global Pharma-Grade Hyaluronic Acid Consumption Value by Region (2020-2031)
4.1.3 Global Pharma-Grade Hyaluronic Acid Average Price by Region (2020-2031)
4.2 North America Pharma-Grade Hyaluronic Acid Consumption Value (2020-2031)
4.3 Europe Pharma-Grade Hyaluronic Acid Consumption Value (2020-2031)
4.4 Asia-Pacific Pharma-Grade Hyaluronic Acid Consumption Value (2020-2031)
4.5 South America Pharma-Grade Hyaluronic Acid Consumption Value (2020-2031)
4.6 Middle East & Africa Pharma-Grade Hyaluronic Acid Consumption Value (2020-2031)
5 麻豆原创 Segment by Type
5.1 Global Pharma-Grade Hyaluronic Acid Sales Quantity by Type (2020-2031)
5.2 Global Pharma-Grade Hyaluronic Acid Consumption Value by Type (2020-2031)
5.3 Global Pharma-Grade Hyaluronic Acid Average Price by Type (2020-2031)
6 麻豆原创 Segment by Application
6.1 Global Pharma-Grade Hyaluronic Acid Sales Quantity by Application (2020-2031)
6.2 Global Pharma-Grade Hyaluronic Acid Consumption Value by Application (2020-2031)
6.3 Global Pharma-Grade Hyaluronic Acid Average Price by Application (2020-2031)
7 North America
7.1 North America Pharma-Grade Hyaluronic Acid Sales Quantity by Type (2020-2031)
7.2 North America Pharma-Grade Hyaluronic Acid Sales Quantity by Application (2020-2031)
7.3 North America Pharma-Grade Hyaluronic Acid 麻豆原创 Size by Country
7.3.1 North America Pharma-Grade Hyaluronic Acid Sales Quantity by Country (2020-2031)
7.3.2 North America Pharma-Grade Hyaluronic Acid Consumption Value by Country (2020-2031)
7.3.3 United States 麻豆原创 Size and Forecast (2020-2031)
7.3.4 Canada 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Mexico 麻豆原创 Size and Forecast (2020-2031)
8 Europe
8.1 Europe Pharma-Grade Hyaluronic Acid Sales Quantity by Type (2020-2031)
8.2 Europe Pharma-Grade Hyaluronic Acid Sales Quantity by Application (2020-2031)
8.3 Europe Pharma-Grade Hyaluronic Acid 麻豆原创 Size by Country
8.3.1 Europe Pharma-Grade Hyaluronic Acid Sales Quantity by Country (2020-2031)
8.3.2 Europe Pharma-Grade Hyaluronic Acid Consumption Value by Country (2020-2031)
8.3.3 Germany 麻豆原创 Size and Forecast (2020-2031)
8.3.4 France 麻豆原创 Size and Forecast (2020-2031)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Russia 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Italy 麻豆原创 Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Pharma-Grade Hyaluronic Acid Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Pharma-Grade Hyaluronic Acid Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Pharma-Grade Hyaluronic Acid 麻豆原创 Size by Region
9.3.1 Asia-Pacific Pharma-Grade Hyaluronic Acid Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Pharma-Grade Hyaluronic Acid Consumption Value by Region (2020-2031)
9.3.3 China 麻豆原创 Size and Forecast (2020-2031)
9.3.4 Japan 麻豆原创 Size and Forecast (2020-2031)
9.3.5 South Korea 麻豆原创 Size and Forecast (2020-2031)
9.3.6 India 麻豆原创 Size and Forecast (2020-2031)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2020-2031)
9.3.8 Australia 麻豆原创 Size and Forecast (2020-2031)
10 South America
10.1 South America Pharma-Grade Hyaluronic Acid Sales Quantity by Type (2020-2031)
10.2 South America Pharma-Grade Hyaluronic Acid Sales Quantity by Application (2020-2031)
10.3 South America Pharma-Grade Hyaluronic Acid 麻豆原创 Size by Country
10.3.1 South America Pharma-Grade Hyaluronic Acid Sales Quantity by Country (2020-2031)
10.3.2 South America Pharma-Grade Hyaluronic Acid Consumption Value by Country (2020-2031)
10.3.3 Brazil 麻豆原创 Size and Forecast (2020-2031)
10.3.4 Argentina 麻豆原创 Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Pharma-Grade Hyaluronic Acid Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Pharma-Grade Hyaluronic Acid Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Pharma-Grade Hyaluronic Acid 麻豆原创 Size by Country
11.3.1 Middle East & Africa Pharma-Grade Hyaluronic Acid Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Pharma-Grade Hyaluronic Acid Consumption Value by Country (2020-2031)
11.3.3 Turkey 麻豆原创 Size and Forecast (2020-2031)
11.3.4 Egypt 麻豆原创 Size and Forecast (2020-2031)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2020-2031)
11.3.6 South Africa 麻豆原创 Size and Forecast (2020-2031)
12 麻豆原创 Dynamics
12.1 Pharma-Grade Hyaluronic Acid 麻豆原创 Drivers
12.2 Pharma-Grade Hyaluronic Acid 麻豆原创 Restraints
12.3 Pharma-Grade Hyaluronic Acid Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Pharma-Grade Hyaluronic Acid and Key Manufacturers
13.2 Manufacturing Costs Percentage of Pharma-Grade Hyaluronic Acid
13.3 Pharma-Grade Hyaluronic Acid Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Pharma-Grade Hyaluronic Acid Typical Distributors
14.3 Pharma-Grade Hyaluronic Acid Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Bloomage Biotech
AWA Biopharm
Kewpie
Contipro
Seikagaku
HTL Biotechnology
贵颈诲颈补听贵补谤尘补肠别耻迟颈肠颈
听
听
*If Applicable.
